2011
DOI: 10.1038/nm.2512
|View full text |Cite
|
Sign up to set email alerts
|

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

22
401
0
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 434 publications
(430 citation statements)
references
References 60 publications
22
401
0
2
Order By: Relevance
“…These results intensively imply that miR-141 acts as an inhibitor of pancreatic cancer tumorigenesis. Our data are in accordance with those of Du and colleagues (25) who showed miR-141 inhibited the proliferation of gastric cancer cells, but is in contrast to other studies that suggest miR-141 acts as an oncogene in ovarian (20) and colon cancers (21). These observations suggest that miR-141 has a heterogeneous role in tumorigenesis that may be highly dependent on its targets in different cells.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…These results intensively imply that miR-141 acts as an inhibitor of pancreatic cancer tumorigenesis. Our data are in accordance with those of Du and colleagues (25) who showed miR-141 inhibited the proliferation of gastric cancer cells, but is in contrast to other studies that suggest miR-141 acts as an oncogene in ovarian (20) and colon cancers (21). These observations suggest that miR-141 has a heterogeneous role in tumorigenesis that may be highly dependent on its targets in different cells.…”
Section: Discussionsupporting
confidence: 92%
“…Recent data have shown that miR-141 and miR-200c play important roles in tumorigenesis. For example, miR-141 increases in ovarian cancer (20) and colon cancer (21) and acts as an oncogene. Other researches show miR-141 is downregulated in renal cell carcinoma (22), breast cancer (23), and pancreatic cancer (24), and can inhibit cell growth in gastric cancer (25).…”
Section: Introductionmentioning
confidence: 99%
“…miR-141 and miR-200a have been found to act as repressors of Dlx5 and Osx expression, and it has been demonstrated that both bind to Dlx5 mRNA in vitro (Itoh et al 2009). Moreover, miR-141 and miR-200a target p38a (Mapk14) in mouse models of ovarian cancer, in agreement with previous screenings in human ovarian adenocarcinomas (Mateescu et al 2011). Positive effects of p38 phosphorylation have been observed on Dlx5 transcriptional activity and on Osx stability (Ulsamer et al 2008, Ortuno et al 2010; consequently, the activity of miR-141 and miR-200a in osteoblast lineages is also probably mediated by changes in p38 phosphorylation of Dlx5 and Osx.…”
Section: Mirnas and Osteoblast Differentiationsupporting
confidence: 88%
“…Some of the first studies demonstrated that the expression of the miR-200 family was correlated with the epithelial/mesenchymal phenotype of ovarian cancer cell lines . This study as well as other studies (Bendoraite et al 2010) demonstrated that miR-200a/b/c, miR-141, and miR-429 determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressor proteins ZEB1 and ZEB2 as well as regulating oxidative stress via p38a (Mateescu et al 2011).…”
Section: Ndsupporting
confidence: 75%